Objective: To describe the temporal pattern of otitis media with effusion (OME) resolution for a cohort of nonsyndromic cleft palate children enrolled before palatoplasty and followed through 5 years of age.
Orofacial clefts including cleft lip (CL) and cleft palate (CP) are among the most common congenital abnormalities in humans with a prevalence of approximately 1.6 per 1000 live births (Centers for Disease Control and Prevention, 2006) . Palatal clefts with or without cleft lip (CP 6 CL) adversely affect normal craniofacial growth and development leading to dysmorphologies in the dentition, face, and cranial base; compromise velopharyngeal competence leading to poor speech; and increase the risk for otitis media with effusion (OME) leading to mild to moderate conductive hearing losses when extant (Butow, 1984; Garcia Romero et al., 2004; Kreilborg et al., 2009) . Ideally, this complex of potential problems is managed by an interactive team of specialists representing the disciplines of plastic surgery, dentistry, otolaryngology, speech pathology, audiology, and social work, among others (Butow, 1984; Sadove et al., 2004) . Important to the clinical management of CP patients is the choice of surgical protocol (timing, technique, etc.) for palatal reconstruction with consideration given to aesthetics, restoring ''normal'' growth trajectories, establishing velopharyngeal competency and, perhaps, resolving the underlying condition(s) that predisposes to OME (Nguyen and Sullivan, 1993; Parri et al., 2001; Summerlad, 2009) .
Early studies of infants and young children with CP reported a high prevalence of hearing loss, not affected by the usual methods for palate repair, but progressively lessened with aging throughout childhood and into adolescence (Graham, 1964; Smith, 1968; Moller, 1975 Moller, , 1981 Webster and Eldis, 1978; Fria et al., 1987) . Others showed that the hearing loss was primarily conductive and directly attributable to the concurrent presence of a middle ear (ME) effusion in the absence of acute symptoms of infection (Bess et al., 1976; Smith et al., 1994; Flynn et al., 2009 ), a pathologic condition termed OME (Lokman et al., 1992) . Indeed, screening studies and retrospective chart reviews documented a near universal prevalence of OME in CP infants and young children that, similar with attendant hearing loss, decreased with advancing age (Stool and Randall, 1967; Smith, 1968; Paradise et al., 1969; Fara et al., 1973; Soudijn and Huffstadt, 1975; Moller, 1981; Robinson et al., 1992; Smith et al., 1994) . Retrospective chart reviews and prospective studies reported no relationship between a child's continued OME risk and the presence or absence of CL, CP laterality, or CP type (Tuncbilek et al., 2003) and provided little to no evidence that the typical procedures for palatal repair or modifications in the stepped timing of those procedures resolved OME in the near term (Watson et al., 1986; Dhillon, 1988; Robinson et al., 1992; Nunn et al., 1995) . Other studies comparing palatoplasty methods with respect to lessening a child's future OME risk (e.g., age 5 and older) reported inconsistent results that were difficult to interpret because of their small per-group sample sizes, lack of appropriate controls (blinding, random assignment, etc.), use of surrogate outcomes to quantify OME persistence (e.g., number of ventilation tubes (VT) insertions, hearing levels, etc.), or use of cross-sectional OME prevalence at a single time as the evaluation endpoint (Butow et al., 1991; Spauwen et al., 1992; Hassan and Askar, 2007; Smith et al., 2008; Flores et al., 2010; Antonelli et al., 2011; Koudoumnakis et al., 2012; Carroll et al., 2013; Tiwari et al., 2013) . Presently, there is no accepted clinical protocol to manage OME in CP, and this remains an issue of debate (Crysdale, 1976; Shaw et al., 2003; Phua et al., 2009; Ponduri et al., 2009; Klockars and Rautio, 2012) .
To define best management practices for OME in CP children, there is a recognized need for well-controlled, prospective, preferably blinded studies that evaluate the comparative efficacy of specified interventions intended to decrease future OME risk (Sadove et al., 2004; Carroll et al., 2013) . A prerequisite to designing such studies is the need for a better description of the typical time course for OME risk in CP children. This is necessary to define the most appropriate outcome measure (e.g., presence or absence of OME at a specified age, OME ''survival curves'' across ages) and to estimate the sample size needed to detect betweengroup differences in the chosen outcome at a specified statistical power. Moreover, it is expected that unidentified constitutive factors modify the time course for OME risk in CP children. Appropriately designed clinical trials would include those factors as stratifying variables or would confine the enrolled population to those children with a moderate to high risk for continued OME expression. Past studies do not capture this information because they report simple OME prevalence by age, with an OME diagnosis made using different methods with varying accuracies and largely ignoring child-specific effects that impact future OME risk (Graham, 1964; Moller, 1975; Ovesen and Blegvad-Andersen, 1992; Robinson et al., 1992; Smith et al., 1994; Handzic-Cuk et al., 2001; Sheahan et al., 2002; Timmermans et al., 2006; Flynn et al., 2009; Szabo et al., 2010; Flynn et al., 2013) . Here we report the longitudinal time course for OME expression in a cohort of similarly managed CP infants followed through 5 years of age.
METHODS
The data for this report were abstracted from those available for an ongoing, prospective, longitudinal study of craniofacial form, Eustachian tube (ET) function, and middle ear (ME) status in CP children from presentation to the Cleft Palate Craniofacial Clinic at the Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (CPCC-UPMC, 3 months to 12 months of age) through 6 years of age. The parents of all nonsyndromic infants with CP presenting to that clinic for longterm management of their child were informed of the study by a member of the study team who then explained the study design, parental obligations, and study procedures to those parents expressing interest. When a parent agreed to enroll his or her child, an informed consent form for study participation was reviewed and signed by the child's parents and a member of the study staff. The full protocol was reviewed and approved by the University of Pittsburgh Institutional Review Board. A total of 82 infants with nonsyndromic CP (with or without CL) were enrolled.
For this study, the standard assessment, treatment, and management protocol for CP infants operational at CPCC-UPMC was supplemented by additional parent-child visits to the research clinics of the Division of Pediatric Otolaryngology, Department of Otolaryngology, University of Pittsburgh. The research clinic visits were scheduled for the children pre-and postpalatoplasty and then yearly through 6 years of age. At each research clinic visit, an interval history was taken, an ear, nose, and throat (ENT) exam performed, ME status assessed by pneumatic otoscopy and tympanometry, and beginning at 3 years of age, ET function was tested using standard manometric techniques if the tympanic membrane was not intact or a pressure-chamber protocol if the tympanic membrane was intact ). In addition, information related to craniofacial form was obtained from cephalometric X-rays done at 5 to 6 years of age on all enrolled children and on ET morphology from MRIs done at 4 and 6 years of age in a subset of the children. Information related to the timing and type of all surgical procedures and the ME status and hearing assessments performed at clinical CPCC-UPMC visits was collected by periodic reviews of patient records maintained by the CPCC-UPMC and ENT clinic at Children's Hospital.
For each assessment of ME status at the research clinic, the integrity of the right and left tympanic membranes was coded as intact or nonintact and, if nonintact, the presence or absence of a VT and its functionality, or of a perforation, and the presence or absence of otorrhea through the tube or perforation were recorded in the study chart. For ears with intact tympanic membranes, physician-diagnosed ME status was coded and recorded as acute otitis media, OME, or ''no disease.'' This information for all study visits and clinical examinations in addition to the ear-canal volume, tympanic membrane compliance, and ME-ambient pressure-gradient recorded by tympanometry if done, the results of any audiometric testing done at the CPCC-UPMC, and the dates and type of all surgical procedures were entered routinely into a computer file independently by two staff members. All paired records were compared periodically and identified discrepancies were reconciled by referral to the primary data source (e.g., study records, patient records). The reconciled database was then locked to retrospective change and used as the source file for all analyses.
For this report, the data for all enrolled children who reached 5 years of age and had a study visit(s) at some time between their fifth and sixth birthdays were abstracted from that database and analyzed. There the codes for ME status on sequential observations for each ear were examined by two investigators to identify the age in years (i.e., ,1, 1, 2, 3, 4, and 5 years) at the first observation of ME status coded as ''no disease'' not followed by ME assessment with an alternative status code (i.e., VT, perforation, otorrhea, acute otitis media, or OME). This was defined as the age at OME resolution (AOR). For ears that had not resolved their OME by or during the fifth year of life, the AOR was assigned a value of ''.5 years.'' No AOR could be assigned to ears with one or more sequential ''no disease'' assignments followed by a VT insertion because of identified disease in the contralateral ear that was present for all assessments during the fifth year of life. For all ears, the AORs recorded by the two investigators were compared, and identified discrepancies were reconciled by referral to the primary database.
To describe the temporal pattern for resolution of OME in this cohort, functions relating the cumulative frequencies of ears and persons to the AOR (for persons, the greater AOR for the right and left ears) were constructed and the parameters of best-fit curves to these functions were estimated using the least-squares method. Also, each child was classified with respect to whether OME had resolved bilaterally before or during the fifth year of life. The effect of sex, race, Veau type, and presence or absence of CL on the assignment to either the OME-resolved or OME-unresolved subgroup was tested for significance using indepen-dent, continuity corrected chi-square tests. The format of average 6 standard deviation was used consistently.
RESULTS
A total of 52 (43 with CL) of the 82 enrolled CP children had at least one study visit between their fifth and sixth birthday, that is, are older than 5 years of age. For these children, follow-up extended through the ages of 5, 6, 7, 8, and 9 years in 10, 24, 7, 8, and 3 children, though the present analysis only considers the ME status through the fifth year of life.
In this subgroup, 29 children were boys and the distribution of parent-assigned race for their child was 45 white, 2 black, 3 Asian, and 2 ''mixed race.'' Of the palatal clefts, 2, 11, 27, and 12 were classified as Veau 1 through 4, respectively. The average age at lip repair (n ¼ 43) was 0.51 6 0.14 years and at palate repair was 1.13 6 0.24 years, and all children had bilateral VTs inserted at the time of lip or palate repair as prescribed by the CPCC management protocol. In addition, bilateral VTs were inserted if OME recurred in either ear after the previous VT became nonfunctional. Palate repair was performed by one of six surgeons with a distribution of 31, 14, 3, 2, 2, and 1 cases per surgeon using the Furlow procedure alone (n ¼ 50) or a procedure described in the chart as a double opposing zplasty (n ¼ 2). The average number of bilateral ME evaluations during follow-up in this cohort was 10.1 6 3.1 (median ¼ 9, range ¼ 6 to 20) with all years represented for both ears of each child. Through the age of 5 years, 26, 13, 6, 4, and 3 children had 0, 1, 2, 3, and 4 bilateral VT reinsertions. One child (male, mixed race, Veau 4, right and left AOR ¼ 2 and 5 years) had a revised palatoplasty at 1.9 years of age and one child (male, white, Veau 1, right and left AOR¼4 and 2 years) had a tonsillectomy at 3.5 years of age.
Prior to insertion of the first set of VTs, OME was not diagnosed in one ear of three children or in both ears of two children, but was diagnosed in all other ears (93%). Figure  1 shows the cumulative percent frequency of ears and children as a function of their AOR in years. Two children (4%) had no observations of OME in either ear at any time during follow-up. For the cohort, the cumulative percent of ears/children with OME resolution increased from 14.3%/ 10.9% at age ,1 year to 70.4%/60.9% at 5 years of age. Curve-fitting showed that the linear equations, Percent Resolution (Ears) ¼ 3.4 þ 13.5 3 Age, and Percent Resolution (Children) ¼ 1.1 þ 11.9 3 Age, explained 99% of the variance in the distribution of those AORs (r 2 ¼.99, P , .01 for both), documenting strict linearity.
By the endpoint for this analysis (through 5 years of age), 14 left and 14 right ears (18 children) had not and 35 left and 34 right ears (28 children) had resolved their OME. Resolution status could not be assigned for three left and four right ears (six children) because of the presence of a patent VT for all observations during 5 years of age in combination with a pre-VT sequence of ''no-disease'' diagnoses. The right-left agreement with respect to OME resolution was 80%, that is, 9 bilaterally unresolved, 28 bilaterally resolved, and 9 unilaterally resolved (P , .01). On last testing, the distribution of tympanometric types for the 69 ears with OME resolution was 55 type A (78.7%, average pressure ¼ À39 6 40 daPa, average compliance ¼ 0.6 6 0.4 ml), 0 type B (0%), and 14 type C (20.3%, average pressure¼À250 6 65 daPa, average compliance¼ 0.8 6 0.5 ml). Table 1 cross-tabulates the frequency distribution of children for the OME-resolved and -unresolved groups by sex, race, Veau type, and presence or absence of CL. None of those variables was a significant predictor of the child's subgroup assignment (all P . .05).
Of interest is the fact that only a single episode of acute otitis media was diagnosed in one ear of two children during follow-up. In contrast, otorrhea through the VT or perforation was relatively frequent (at least once in 40% of the children), occurring unilaterally in 12 children and bilaterally in 9 children, with repeat episodes in four ears. Past otorrhea was not predictive of subgroup assignment occurring in 33% and 39% in the unresolved and resolved subgroups, respectively (P . .05).
DISCUSSION
OME, defined as an inflammation of the ME mucosa with varying amounts of accumulated fluid (i.e., effusion) within the normally air-filled ME cavity, is a relatively common presentation in infants and children (Bluestone and Klein, 2007) . When extant, the ME fluid (i.e., effusion) dampens free movements of the tympanic membrane causing a conductive hearing loss that fluctuates in magnitude with changes in fluid volume, spatial distribution, and other factors. Thus, there is not a 1:1 correspondence between extant OME and a detectable hearing loss, and the use of the latter to diagnose the former is neither specific nor sensitive. Although the etiology of OME is believed to be multifactorial, an effect common to all is impairment of the Eustachian tube opening function (Bluestone, 2005) , a pathophysiology known to precipitate a disease condition not different from OME (Casselbrant et al., 1985) . Most OME episodes are of short duration, but in a subset of children believed to be characterized by constitutively poor ET opening function, OME can persist for years. In those cases, no medical treatment effects disease resolution, but the probability of continued OME decreases with advancing age such that these children tend to ''outgrow'' their disease risk. The possibility of long-term hearing loss in children affected by persistent OME is typically managed by VT insertion, which re-establishes ME pressure-regulation, promotes the clearance of ME fluid, and restores near-normal hearing. However, this intervention is not without complications such as otorrhea through the tube and sequelae such as tympanic membrane scarring and thinning. Moreover, VTs are spontaneously extruded from the tympanic membrane over time with recurrence of persistent OME if the ET opening efficiency had not normalized during the interval (Bluestone and Klein, 2007) . The population of children with congenital CP is characterized by a near universal prevalence of OME in infancy and a much higher OME prevalence at all ages when compared with the respective populations of infants, children, adolescents, and adults born without palatal clefts (Graham, 1964; Stool and Randall, 1967; Smith, 1968; Paradise et al., 1969; Moller, 1981; Flynn et al., 2009; Flynn et al., 2013) . These data indicate an exceedingly high risk for persistent OME or, less likely, recurrent OME in CP infants that slowly decreases with advancing age. This risk is usually attributed to the abnormal morphology and spatial vectors for the ET and paratubal muscles characteristic of CP infants and children, an anatomy that imposes a constitutively poor ET opening efficiency (Doyle et al., 1986) . If correct, the functional-anatomic deficiencies in the ET opening mechanism in CP children are not caused solely by the patent nasal-oral communication, as closure of the palatal defect using standard methods does not appreciably change OME risk (Watson et al., 1986; Dhillon, 1988; Robinson et al., 1992; Nunn et al., 1995) . However, a degree of functional-anatomic normalization is achieved by adaptation and/or maturation during growth and development as reflected in the decreasing OME prevalence with aging in CP children (Moller, 1975; Robinson et al., 1992; Sheahan et al., 2002; Flynn et al., 2009; Szabo et al., 2010; Flynn et al., 2013) .
For the population, an intrinsic variability in the degree of functional-anatomic deficiency across individual CP infants and children at any specified age is expected. This would be expressed as variability across children in the OME risk at a given age. The distribution of these risks within a population is an important parameter for estimating the group sample sizes required to achieve specified statistical powers for detecting ''true'' betweengroup differences in comparative studies of risk-modifying interventions. Also, the identification of individual characteristics that discriminate CP children with high and low future OME risks would prove useful in predicting future disease experience for a given child and may well define a set of candidate risk modifiers for targeted intervention.
The hypothesized variability in OME risk across CP infants cannot be tested using published data because all past studies report simple prevalence estimates for defined age groups irrespective of whether the design was a crosssectional sampling across ages for a population or a longitudinal follow-up of individuals across ages within a population (Moller, 1975; Robinson et al., 1992; Sheahan et al., 2002; Flynn et al., 2009; Szabo et al., 2010; Flynn et al., 2013) . These prevalence data are applicable only to populations and cannot be translated to individual risk assignments. Here, we analyzed longitudinal ME status data prospectively collected for a cohort of CP infants followed through 5 years of age to describe the distribution of the disease course for individual children. This analysis treated OME in CP children as a persistent (or recurrent) condition that resolves at different ages in different individuals reflecting the contribution of child-related factors to the variability in OME risk.
The results of this analysis documented the expected interchild variability in continued OME risk as reflected in the wide distribution of resolution ages. The across-age distributions of ears and individuals with respect to continued OME risk was ''flat'' such that approximately equal numbers of ears or children in the cohort resolved their OME at ages 2, 3, 4, and 5 years. This distribution ''shape'' largely discounts an effect of palatoplasty on near or future OME risk because the expected spike in frequency of children with OME resolution at 1 and 2 years of age, assuming such an effect, was not detected. The contribution of the child-related factors to the variability in continued OME risk is supported by the high left-right ear agreement in the OME resolution assignment at 5 years of age, which strongly suggests that such factors couple the continued OME risks for the two ears of a child.
The distribution of resolution ages shown in the figure allows for estimation of the frequency of CP children with OME resolution at each age and the assignment of individual children to resolved or unresolved subgroups at any age. We suggest that the differences in the characteristics of individuals between the 2 subgroups defined at a specified age captures factors that directly impact OME risk. In a first exploration of this possibility, the effects of sex, race, presence or absence of CL, and Veau type on subgroup assignment were tested, but none were significant predictors of disease resolution through 5 years of age. However, this study was not designed to test such hypotheses and the power to detect ''true'' differences for these comparisons was low. Nonetheless, with a larger sample size and the inclusion of other factors, this type of analysis promises to identify a set of risk modifiers that can be targeted for intervention. Indeed, at the completion of follow-up on all children enrolled in the primary study, we plan to test the predictive value with respect to AOR of the measured ET functional efficiency and structural dysmorphologies assessed at earlier ages. Also, the cumulative distribution of the frequencies of OME resolution by age can be recast as a ''survival curve'' for OME persistence over time. Such curves contain significantly more information than is represented in simple dichotomous subgroup assignments. Consequently, in designing clinical studies comparing interventions to lower OME risk in CP children, smaller sample sizes can be accommodated by taking advantage of this information and analyzing study results using statistical techniques for between-group comparisons of these ''survival curves.''
The assignment of AORs based on longitudinal ME status data for individual ears and children assumes that the probability of OME during a given year is conditioned by the previous year's ME status, and specifically that, for a given ear, a diagnosis of ''no disease'' significantly reduces the probability (i.e., risk) of an OME diagnosis at a later time for the same ear. This assumption is supported by examination of the temporal data for individual ears in this cohort where a no-disease assignment on any two sequential observations was followed by an OME diagnosis at any time in only 19 ears (18%), with 9 of those cases (47%) representing a single OME diagnosis embedded within a string of no-disease observations. To be conservative in assigning an AOR for individual ears, any OME observation was interpreted as evidence of continuously persistent OME to that age though it is more probable that short-duration OME episodes after a long string of ''no disease'' observations is caused by an etiologic factor such as an upper respiratory virus infection that transiently depresses ET opening efficiency and does not reflect a constitutive degree of inefficiency sufficient for disease presentation as persistent OME. To definitively answer this question, a greater sample density across all ages would be required and is recommended for incorporation into the design of future studies.
One limitation to this analysis is that AORs assigned at 5 years of age are presumably less reliable than those assigned at younger ages where the string of ''no-disease'' observations from that age through the age of 5 years strengthens confidence in the assignment. This possibility was examined using data for the complete period of follow-up available from the primary database. Of the 14 ears with an AOR assigned at 5 years, 10 had follow-up data through older ages with no OME diagnoses in those ears.
In summary, the risk for OME in cleft palate infants is not affected by palatoplasty, but decreases with advancing age. There was a significant contribution of the individual to the observed variability in the AOR, suggesting that factors characteristic of the individual impact continued disease risk. In this cohort, the temporal pattern of disease assignments was consistent with that expected for persistent rather than recurrent OME, and diagnoses of acute OM were rare. All children had bilateral VTs inserted at the time of lip and/or palate repair and on observation of at least unilateral OME after the VT had become dysfunctional. As previously reported (Curtin et al., 2009) , otorrhea through the tube was a common complication but this did not increase future disease risk. Overall, persistent OME had resolved in approximately 70% of the ears and 60% of the children by a child's sixth birthday, but these rates should be referenced to populations where OME was managed similarly to that of the CPCC-UPMC as described in the Methods and Results sections.
